Patents for A61P 19 - Drugs for skeletal disorders (81,981)
02/2008
02/07/2008WO2007121484A3 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling
02/07/2008WO2007054309A3 Use of clodronic acid for the treatment of navicular syndrome
02/07/2008US20080033170 Novel compounds
02/07/2008US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders
02/07/2008US20080033049 Hydroxy-Biphenyl-Carbaldehyde Oxime Derivatives and Their Use As Estrogenic Agents
02/07/2008US20080033033 8-azaprostaglandin derivatives and medical use thereof
02/07/2008US20080033013 Pyrazolylphenyl and pyrrolylphenyl inhibitors of lta4h for treating inflammation
02/07/2008US20080032997 (5S)-5-methyl-5-({[6-[2-(trifluoromethyl)pyrimidin-5-yl]-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)imidazolidine-2,4-dione; asthma, rhinitis, chronic obstructive pulmonary diseases (COPD), arthritis (such as rheumatoid arthritis and osteoarthritis), atherosclerosis, cancer
02/07/2008US20080032991 2, 8-disubstituted Naphthyridine Derivatives
02/07/2008US20080032989 Method of treating inflammatory diseases using tyroskine kinase inhibitors
02/07/2008US20080032988 Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use
02/07/2008US20080032981 Aryl n-cyanoguanidines and methods related thereto
02/07/2008US20080032973 2-Quinazolinone compounds and methods of use
02/07/2008US20080032969 Novel compounds
02/07/2008US20080032959 Estrogen Receptor Modulators
02/07/2008US20080032958 Withanolide compounds as inhibitors of fibrosis and identification of molecular targets for anti-fibrotic drug development
02/07/2008US20080032956 2-Ethyl and 2-Ethylidene-19-Nor-Vitamin D Compounds
02/07/2008US20080032934 Compositions for prevention of adhesions and other barrier applications
02/07/2008US20080032919 BMP-7 Variant Compositions, Methods and Uses
02/07/2008US20080032336 Chemokine receptor materials and methods
02/07/2008US20080031958 Composition for accelerating bone fracture healing
02/07/2008US20080031936 Immunostimulatory nucleic acid molecules
02/07/2008US20080031923 Biologic Replacement for Fibrin Clot
02/07/2008US20080031916 Dendrimer cross-linked collagen
02/07/2008US20080031915 Cartilage and Bone Repair Composition
02/07/2008US20080031875 Treatment method
02/07/2008CA2693378A1 Myostatin antagonists
02/07/2008CA2659846A1 Parathyroid hormone analogues and methods of use
02/07/2008CA2659542A1 Methods and compositions for inhibiting angiogenesis
02/07/2008CA2659539A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
02/07/2008CA2659336A1 Certain 1h-imidazo[4,5-b]pyrazin-2(3h)-ones and 1h-imidazo[4,5-b]pyrazin-2-ols, compositions thereof and their use
02/07/2008CA2655682A1 Delayed-release glucocorticoid treatment of rheumatoid disease
02/07/2008CA2649044A1 Benzylphenyl glucopyranoside derivative
02/06/2008EP1884240A1 Pharmaceutical for prevention or treatment of bone metabolic disease
02/06/2008EP1883644A2 Process of making geminal bisphosphonic acids and pharmaceutically acceptable salts and/or hydrates thereof
02/06/2008EP1883416A2 Compositions and methods for the prevention and treatment of conditions associated with inflammation
02/06/2008EP1309596B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases
02/06/2008EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation
02/06/2008CN101119987A Novel compounds
02/06/2008CN101119986A Optically active tetrahydronaphthalene derivative
02/06/2008CN101119978A HSP90-inhibiting triazole derivatives
02/06/2008CN101119738A Herbal mixture extract of notoginseng radix, rehmanniae radix preparata and acanthopanacis cortex and composition comprising the same for prevention and treatment of arthritis
02/06/2008CN101119725A Solid forms of a chemokine receptor antagonist and methods of use thereof
02/06/2008CN101119716A External plaster containing flurbiprofen
02/06/2008CN101116748A Adriablastina antineoplastic medicine and gland correlated virus composite preparations and uses thereof
02/06/2008CN101116747A Cytosine arabinoside and gland correlated virus composite preparations and uses thereof
02/06/2008CN101116707A Oral Chinese traditional medicine composition for treating gout
02/06/2008CN101116705A Pill for treating projecting lumbar vertebrae
02/06/2008CN101116683A Medicine for treating arthritis
02/06/2008CN101116682A Chinese traditional medicine special for treating chilblain
02/06/2008CN101116677A Compound milettia reticulata capsule and method for preparing the same
02/06/2008CN101116676A Method for preparing compound milettia reticulata particles
02/06/2008CN101116674A Mongolian medicine for treating bone fracture
02/06/2008CN100366606C New phenylamidine derivatives process for preparing the same and their use as medicaments
02/06/2008CN100366296C Process for preparing a sterile high molecular weight hyaluronic acid formulation
02/06/2008CN100366285C Medicine, and its preparing method and use for treating arthritis by external application
02/06/2008CN100366260C Astragalus glycoside fatty emulsion and its preparation technology
02/06/2008CN100366245C Oil from momordica charantia L., its method of preparation and uses
02/06/2008CN100366199C Traditional medicine dog skin knee pad
02/05/2008US7326801 2-amino-propanol derivatives
02/05/2008US7326723 Autoimmune disease; antiinflammatory agents
02/05/2008US7326715 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
02/05/2008US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs
02/05/2008US7326696 Amino-methyl substituted tetracycline compounds
02/05/2008CA2417635C Heterocyclic compounds useful as inhibitors of tyrosine kinases
02/05/2008CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
02/05/2008CA2395204C Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials
01/2008
01/31/2008WO2008014054A2 Bmp-7 variant compositions, methods and uses
01/31/2008WO2008013494A1 Quinoline derivatives as p2x7 receptor antagonist and their use in the treatment of rheumatoid arthritis, osteoarthritis, copd and ibd
01/31/2008WO2008012828A2 Composite implants for promoting bone regeneration and augmentation and methods for their preparation and use
01/31/2008WO2008012563A2 Use of cdk inhibitors for the treatment of granulocyte mediated disorders
01/31/2008WO2007102770A8 Gsk-3 inhibitors for the treatment of osteoporosis
01/31/2008WO2007100282A8 New salts of an indole derivative and their use in medicine
01/31/2008WO2007070450A3 Fast-acting oral peptide pharmaceutical products
01/31/2008US20080027123 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating erythema nodosum leprosum in leprosy, rhematoid spondylitis, hepatitis or congestive heart failure
01/31/2008US20080027084 antiinflammatory agent, anticarcinogenic agent; for treating inflammatory diseases, allergic, autoimmune, metabolic, cancer, cardiovascular diseases
01/31/2008US20080027083 Modulators of chemokine receptor activity crystalline forms and process
01/31/2008US20080027081 Therapeutic compounds
01/31/2008US20080027080 Cyclic derivatives as modulators of chemokine receptor activity
01/31/2008US20080027070 2-amino--5-substituted pyrimidine inhibitors
01/31/2008US20080027061 omega-Carboxy Aryl Substituted Diphenyl Ureas As p38 Kinase Inhibitors
01/31/2008US20080027060 Dipeptide nitriles
01/31/2008US20080027050 Heterocyclic Amide Compound and Use Thereof as an Mmp-13 Inhibitor(Amended Ex Officio)
01/31/2008US20080027048 2-Phenylthiophene Derivative
01/31/2008US20080027038 N-Acylated lipophilic amino acid derivatives
01/31/2008US20080027036 S1P receptor modulating compounds and use thereof
01/31/2008US20080027032 Combinations comprising cox-2 inhibitors and aspirin
01/31/2008US20080027013 Antibacterial treatment of osteoarthritis
01/31/2008US20080026980 Use of Agents Derived from Ceacam1 for the Treatment of Inflammatory Diseases
01/31/2008US20080026402 Hematopoietin receptors HPR1 and HPR2
01/31/2008US20080026080 Reacting a gluconic acid with lactic acid in the presence of calcium hydroxide and water to obtain a calcium gluconolactate molecule having the formula HO-CH2-(CHOH)4-COO-Ca-OOC-CH(-OH)-CH3 with molecular weight of 324.2994; physical and chemical properties; nutraceuticals
01/31/2008US20080026049 Liposomal compositions for parenteral delivery of agents
01/31/2008US20080026037 Compositions Comprising Strontium and Vitamin D and Uses Thereof
01/31/2008US20080026032 Composite implants for promoting bone regeneration and augmentation and methods for their preparation and use
01/31/2008US20080026011 Immunostimulatory nucleic acid molecules
01/31/2008US20080025978 High affinity ligand for p75 neurotrophin receptor
01/31/2008US20080025976 Methods of treating ankylosing spondylitis using anti-TNF antibodies and peptides of human tumor necrosis factor
01/31/2008DE102006035083A1 Proteinbindende Methotrexat-Derivate und diese enthaltende Arzneimittel Protein-binding methotrexate derivatives and pharmaceutical compositions containing them
01/30/2008EP1882690A2 A process for the preparation of epothilone analogs and intermediates
01/30/2008EP1882684A1 Pyrrolidine derivative or salt thereof